BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

568 related articles for article (PubMed ID: 25774617)

  • 1. Immune approaches to the treatment of breast cancer, around the corner?
    Criscitiello C; Esposito A; Gelao L; Fumagalli L; Locatelli M; Minchella I; Adamoli L; Goldhirsch A; Curigliano G
    Breast Cancer Res; 2014 Feb; 16(1):204. PubMed ID: 25774617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Developing an effective breast cancer vaccine: challenges to achieving sterile immunity versus resetting equilibrium.
    Curigliano G; Criscitiello C; Esposito A; Fumagalli L; Gelao L; Locatelli M; Minchella I; Goldhirsch A
    Breast; 2013 Aug; 22 Suppl 2():S96-9. PubMed ID: 24074802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunotherapy of Breast Cancer.
    Criscitiello C; Curigliano G
    Prog Tumor Res; 2015; 42():30-43. PubMed ID: 26377084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunology and breast cancer: toward a new way of understanding breast cancer and developing novel therapeutic strategies.
    Gingras I; Azim HA; Ignatiadis M; Sotiriou C
    Clin Adv Hematol Oncol; 2015 Jun; 13(6):372-82. PubMed ID: 26352893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunology and breast cancer: therapeutic cancer vaccines.
    Curigliano G; Rescigno M; Goldhirsch A
    Breast; 2007 Dec; 16 Suppl 2():S20-6. PubMed ID: 17706425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunotherapy of breast cancer.
    Wright SE
    Expert Opin Biol Ther; 2012 Apr; 12(4):479-90. PubMed ID: 22413825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic and predictive immune gene signatures in breast cancer.
    Bedognetti D; Hendrickx W; Marincola FM; Miller LD
    Curr Opin Oncol; 2015 Nov; 27(6):433-44. PubMed ID: 26418235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic gene modified cell based cancer vaccines.
    Kozłowska A; Mackiewicz J; Mackiewicz A
    Gene; 2013 Aug; 525(2):200-7. PubMed ID: 23566846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunotherapy for the treatment of breast cancer: checkpoint blockade, cancer vaccines, and future directions in combination immunotherapy.
    McArthur HL; Page DB
    Clin Adv Hematol Oncol; 2016 Nov; 14(11):922-933. PubMed ID: 27930644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunotherapy for the treatment of breast cancer.
    Ernst B; Anderson KS
    Curr Oncol Rep; 2015 Feb; 17(2):5. PubMed ID: 25677118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunotherapy strategies in the treatment of breast cancer.
    Soliman H
    Cancer Control; 2013 Jan; 20(1):17-21. PubMed ID: 23302903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peptide vaccines in early breast cancer.
    Criscitiello C; Viale G; Curigliano G
    Breast; 2019 Apr; 44():128-134. PubMed ID: 30769238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Breast cancer immunobiology driving immunotherapy: vaccines and immune checkpoint blockade.
    Emens LA
    Expert Rev Anticancer Ther; 2012 Dec; 12(12):1597-611. PubMed ID: 23253225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunotherapy in Breast Cancer.
    Marmé F
    Oncol Res Treat; 2016; 39(6):335-45. PubMed ID: 27260697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Anti-HER2 vaccines: The HER2 immunotargeting future?].
    Ladjemi MZ; Jacot W; Pèlegrin A; Navarro-Teulon I
    Pathol Biol (Paris); 2011 Jun; 59(3):173-82. PubMed ID: 19481373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Yin-yang effect of tumor infiltrating B cells in breast cancer: From mechanism to immunotherapy.
    Zhang Z; Zhu Y; Wang Z; Zhang T; Wu P; Huang J
    Cancer Lett; 2017 May; 393():1-7. PubMed ID: 28216374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The immune response to breast cancer, and the case for DC immunotherapy.
    Allan CP; Turtle CJ; Mainwaring PN; Pyke C; Hart DN
    Cytotherapy; 2004; 6(2):154-63. PubMed ID: 15203992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tecemotide: an antigen-specific cancer immunotherapy.
    Wurz GT; Kao CJ; Wolf M; DeGregorio MW
    Hum Vaccin Immunother; 2014; 10(11):3383-93. PubMed ID: 25483673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The anti-tumor immune response in breast cancer: Update and therapeutic perspectives].
    Ladoire S; Derangère V; Arnould L; Thibaudin M; Coudert B; Lorgis V; Desmoulins I; Chaix M; Fumoleau P; Ghiringhelli F
    Ann Pathol; 2017 Feb; 37(1):133-141. PubMed ID: 28159406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunotherapeutics for breast cancer.
    Criscitiello C; Curigliano G
    Curr Opin Oncol; 2013 Nov; 25(6):602-8. PubMed ID: 24076578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.